DOI: 10.1055/s-00000069

Seminars in Liver Disease

Referenz

Ratziu V, Harrison SA, Francque S. , et al; GOLDEN-505 Investigator Study Group.
Elafibranor, an agonist of the peroxisome proliferator-activated receptor-α and -δ, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening.

Gastroenterology 2016;
150 (05) 1147-1159.e5

Ratziu V, Harrison SA, Francque S. , et al; GOLDEN-505 Investigator Study Group.
Elafibranor, an agonist of the peroxisome proliferator-activated receptor-α and -δ, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening.

Gastroenterology 2016;
150 (05) 1147-1159.e5

Bibliographische Angaben herunterladen

Suchen in:
Aufrufen in: